Skip to main content
Clinical Trials/NCT00428792
NCT00428792
Completed
Phase 3

An Open-label, Randomized, Rater-blinded, Cross-over, Multicenter Study Comparing the Clinical Efficacy of Methylphenidate (Immediate Release/Extended Release) Treatment (20 or 40 mg Orally od) in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Under Different Breakfast Conditions Over Two Weeks

Novartis1 site in 1 country150 target enrollmentApril 2007

Overview

Phase
Phase 3
Intervention
Methylphenidate 20 mg long-acting capsules
Conditions
Attention Deficit Hyperactivity Disorder
Sponsor
Novartis
Enrollment
150
Locations
1
Primary Endpoint
Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Teacher Rating in the Intent-to-Treat (ITT) Population
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

This study evaluated the safety and clinical effect of treatment with methylphenidate under different breakfast conditions (minimal breakfast versus standard continental breakfast) in children with Attention-Deficit Hyperactivity Disorder (ADHD).

Registry
clinicaltrials.gov
Start Date
April 2007
End Date
December 2007
Last Updated
15 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Novartis

Eligibility Criteria

Inclusion Criteria

  • Children aged 6-12
  • Diagnosis of Attention-Deficit Hyperactivity Disorder (ADHD)
  • Current medication with either 20 mg or 40 mg immediate release methylphenidate

Exclusion Criteria

  • Concomitant psychiatric disorders requiring pharmacological treatment
  • Concomitant severe somatic disorders
  • Eating disorders
  • Addiction disorders
  • Very high or low body weight according to age
  • Known hypersensitivity to methylphenidate
  • Contraindications for methylphenidate
  • Other protocol-defined inclusion/exclusion criteria applied to the study.

Arms & Interventions

Very light breakfast (VLB) then standard breakfast (SB)

Very light breakfast (VLB) for one week then crossover to standard breakfast (SB) for one week while taking either 1 or 2 20 mg capsules of methylphenidate once per day based on the dosage the child had taken in the month prior to study start. VLB is defined as 150 kcal for children age 6-9 and 180 kcal for children age 10-12. SB is defined as 450 kcal for girls age 6-9, 490 kcal for boys age 6-9, 550 kcal for girls age 10-12, and 600 kcal for boys age 10-12.

Intervention: Methylphenidate 20 mg long-acting capsules

Standard breakfast (SB) then very light breakfast (VLB)

Standard breakfast (SB) for one week then crossover to very light breakfast (VLB) for one week while taking either 1 or 2 20 mg capsules of methylphenidate once per day based on the dosage the child had taken in the month prior to study start. SB is defined as 450 kcal for girls age 6-9, 490 kcal for boys age 6-9, 550 kcal for girls age 10-12, and 600 kcal for boys age 10-12. VLB is defined as 150 kcal for children age 6-9 and 180 kcal for children age 10-12.

Intervention: Methylphenidate 20 mg long-acting capsules

Outcomes

Primary Outcomes

Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Teacher Rating in the Intent-to-Treat (ITT) Population

Time Frame: Friday of each of the 2 treatment weeks

The FBB-ADHS is a 20-item rating scale. Each item describes a typical ADHD symptom. The 20 items are divided into 3 subscales: Attention deficits (9 items), hyperactivity (7 items), and impulsiveness (4 items). Each item is rated on a scale of 0 = not at all up to 3 = very much. The FBB-ADHS was completed by teachers on Friday afternoon of each week of the study. A total score (sum of all items divided by 20) was calculated. The total score can range from 0 to 3. A lower score indicates more ADHD.

Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Teacher Rating in the Per Protocol (PP) Population

Time Frame: Friday of each of the 2 treatment weeks

The FBB-ADHS is a 20-item rating scale. Each item describes a typical ADHD symptom. The 20 items are divided into 3 subscales: Attention deficits (9 items), hyperactivity (7 items), and impulsiveness (4 items). Each item is rated on a scale of 0 = not at all up to 3 = very much. The FBB-ADHS was completed by teachers on Friday afternoon of each week of the study. A total score (sum of all items divided by 20) was calculated. The total score can range from 0 to 3. A lower score indicates more ADHD.

Secondary Outcomes

  • Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Attention Deficit Subscale Teacher Rating(Friday of each of the 2 treatment weeks)
  • Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Hyperactivity Subscale Teacher Rating(Friday of each of the 2 treatment weeks)
  • Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Impulsiveness Subscale Teacher Rating(Friday of each of the 2 treatment weeks)
  • Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Parent Rating(Saturday of each of the 2 treatment weeks)
  • 10-Minute Math Test - Problems Attempted(Saturday of each of the 2 treatment weeks)
  • 10-Minute Math Test - Problems Solved(Saturday of each of the 2 treatment weeks)
  • Clinical Global Impression Severity (CGI-S) Scale Score - Physician Rating of Severity(Saturday of each of the 2 treatment weeks)
  • Clinical Global Impression (CGI-I) Scale Score - Physician Rating of Improvement (Change in State)(Saturday of each of the 2 treatment weeks)

Study Sites (1)

Loading locations...

Similar Trials